These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15723630)

  • 1. Computer-based strategy for modeling the interaction of AGRP and related peptide ligands with the AGRP-binding site of murine melanocortin receptors.
    Wang X; Richards NG
    Curr Pharm Des; 2005; 11(3):345-56. PubMed ID: 15723630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
    Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
    Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
    Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
    J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
    Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
    ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
    Yang Z; Tao YX
    Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
    Fleming KA; Freeman KT; Ericson MD; Haskell-Luevano C
    J Med Chem; 2018 Sep; 61(17):7729-7740. PubMed ID: 30035543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of melanocortin receptor exoloops to Agouti-related protein binding.
    Yang YK; Dickinson CJ; Zeng Q; Li JY; Thompson DA; Gantz I
    J Biol Chem; 1999 May; 274(20):14100-6. PubMed ID: 10318826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
    Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
    Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
    Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
    Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
    Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
    Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elongation studies of the human agouti-related protein (AGRP) core decapeptide (Yc[CRFFNAFC]Y) results in antagonism at the mouse melanocortin-3 receptor.
    Joseph CG; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Haskell-Luevano C
    Peptides; 2003 Feb; 24(2):263-70. PubMed ID: 12668211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
    Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
    Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
    J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
    Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
    J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse.
    Fekete C; Marks DL; Sarkar S; Emerson CH; Rand WM; Cone RD; Lechan RM
    Endocrinology; 2004 Nov; 145(11):4816-21. PubMed ID: 15256492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.